Andreas Faust

Andreas Faust

Auto-generated profile, based on publicly available information

Andreas Faust

European Institute for Molecular Imaging WWU Münster Waldeyerstrasse 15 48149 Münster Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2017 in ChemMedChem
Verified
Journal Article
Open access
PDF file
AAAlexander Axer
Alexander Axer
SHSven Hermann
Sven Hermann
GKGerald Kehr
Gerald Kehr
DCDavid Clases
David Clases
UKUwe Karst
Uwe Karst
AFAndreas Faust
Andreas Faust
Diagnosis and localization of bacterial infections remains a significant clinical challenge. Harnessing bacteria‐specific metabolic pathways, such as the maltodextrin transport mechanism, may allow specific localization and imaging of small or hidden colonies. This requires that the intrabacterial tracer accumulation provided by the transporter is matched by high serum stability of the tracer molecule. Herein, radiolabeled maltodextrins of varying chain lengths and with free nonreducing/reducing ends are reported and their behavior against starch‐degrading enzymes in the blood, which compromise their serum stability, is evaluated. Successful single‐photon emission computed tomography (SPECT) imaging is shown in a footpad infection model in vivo by using the newly developed model tracer, [99mTc]MB1143, and the signal is compared with that of 18F‐fluorodeoxyglucose positron emission tomography ([18F]FDG‐PET) as a nonbacterial specific marker for inflammation. Although the [99mTc]MB1143 imaging signal is highly specific, it is low, most probably due to insufficient serum stability of the tracer. A series of stability tests with different 18F‐labeled maltodextrins finally yielded clear structural guidelines regarding substitution patterns and chain lengths of maltodextrin‐based tracers for nuclear imaging of bacterial infections.

1 March 2016 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
AGAnzhela Galstyan
Anzhela Galstyan
DBDesiree Block
Desiree Block
SNSilke Niemann
Silke Niemann
MGMalte C. Grüner
Malte C. Grüner
Stefania AbbruzzettiStefania Abbruzzetti
Stefania Abbruzzetti
AFAndreas Faust
Andreas Faust

1 January 2016 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
KSKatrin Schwegmann
Katrin Schwegmann
DBDominik Bettenworth
Dominik Bettenworth
SHSven Hermann
Sven Hermann
AFAndreas Faust
Andreas Faust
CPChristopher Poremba
Christopher Poremba
PLPhilipp Lenz
Philipp Lenz
Patients with ulcerative colitis are at increased risk for colorectal cancer and endoscopic surveillance is mandatory. Matrix metalloproteinases (MMPs)-2 and -9 activities are increased in malignant colonic mucosa. The aim of the study was to evaluate molecular imaging of MMP-2/-9 by fluorescence endoscopy (FE) for early tumor detection. Colorectal cancer in mice (n = 28) was induced by azoxymethane and dextran sodium sulfate. Twenty-four hours after intravenous injection of a nonpeptidic, Cy5.5-labeled MMP-selective tracer, tumor development was assessed in vivo by white light endoscopy and FE. Topical administration of the tracer was also investigated (after 5 minutes and 24 hours). Colonic tumors were evaluated ex vivo by fluorescence reflectance imaging, immunohistochemistry, Western blot analysis, and zymography. Imaging of MMP-2/-9 expression by FE achieved a significantly higher contrast of the fluorescence signal in colonic adenomas compared with the adjacent nonmalignant mucosa (P < 0.001). Fluorescence reflectance imaging detected a significantly higher tracer uptake in adenoma compared with healthy mucosa (P < 0.001) and revealed a tumor size–dependent increase of tracer uptake (P < 0.01). Topical tracer administration did not facilitate tumor detection. Immunohistochemistry, Western blot analysis, and zymography indicated higher levels of MMP-2 and -9 in high-grade dysplasia and pT1 tumors ex vivo. MMP-2/-9 expression was significantly increased in colorectal neoplasia. FE allows direct visualization of a prognostic parameter (here MMP-2/-9) on a molecular level and may improve the characterization of colorectal lesions and the adenoma detection rate in the future.

1 September 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CWChristopher M. Waldmann
Christopher M. Waldmann
SHSven Hermann
Sven Hermann
AFAndreas Faust
Andreas Faust
BRBurkhard Riemann
Burkhard Riemann
OSOtmar Schober
Otmar Schober
Klaus KopkaKlaus Kopka
Klaus Kopka

9 June 2016
Verified
Journal Article
Closed access
AVAlexis Vrachimis
Alexis Vrachimis
LHLisa Honold
Lisa Honold
AFAndreas Faust
Andreas Faust
SHSven Hermann
Sven Hermann
MSMichael Schaefers
Michael Schaefers

6 February 2018 in ChemMedChem
Verified
Journal Article
Open access
PDF file
AAAlexander Axer
Alexander Axer
SHSven Hermann
Sven Hermann
GKGerald Kehr
Gerald Kehr
DCDavid Clases
David Clases
UKUwe Karst
Uwe Karst
AFAndreas Faust
Andreas Faust
The Front Cover shows a blueprint of a defined carbohydrate (candy) that is literally devoured by the bacterial cell via maltodextrin transporters. Attaching an imaging label to this carbohydrate allows it to be tracked (yellow shine) and potentially allows sensitive detection and localization of bacterial infection in vivo. The study has identified essential structural features of the tracer molecule to make it less vulnerable to enzymatic degradation (green icons) in the blood. This approach facilitates intracellular accumulation via maltodextrin transporters thereby lightening up the bacterial cell and colony, respectively. More information can be found in the Full Paper by Ryan Gilmour, Andreas Faust et al. on page 241 in Issue 3, 2018 (DOI: 10.1002/cmdc.201700543).